{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:26:28Z","timestamp":1783661188528,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.clgc.2016.07.022","type":"journal-article","created":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T02:16:36Z","timestamp":1470622596000},"page":"306-312.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors"],"prefix":"10.1016","volume":"15","author":[{"given":"Andrea","family":"Necchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Pond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Giannatempo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Adra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser H.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Salvioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H.","family":"Einhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantine","family":"Albany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2016.07.022_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Cancer Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers","volume":"15","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.07.022_bib2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Guidelines on testicular cancer: 2015 update","volume":"68","author":"Albers","year":"2015","journal-title":"Eur Urol"},{"issue":"suppl 6","key":"10.1016\/j.clgc.2016.07.022_bib3","doi-asserted-by":"crossref","first-page":"vi125","DOI":"10.1093\/annonc\/mdt304","article-title":"Testicular seminoma and non-seminoma: ESMO clinical practice guidelines for diagnosis, treatment, and follow up","volume":"24","author":"Oldenburg","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2016.07.022_bib4","unstructured":"National Comprehensive Cancer Network. NCCN guidelines: Testicular cancer. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/testicular.pdf Accessed: March 31, 2016."},{"key":"10.1016\/j.clgc.2016.07.022_bib5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ejca.2005.08.043","article-title":"Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: an update based on meta-analysis","volume":"42","author":"van Dijk","year":"2006","journal-title":"Eur J Cancer"},{"issue":"suppl 7","key":"10.1016\/j.clgc.2016.07.022_bib6","article-title":"Is the International germ cell cancer consensus classification (IGCCCG) sufficiently predictive in 2015?","volume":"33","author":"Nichols","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.07.022_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clgc.2015.07.021","article-title":"The changing landscape of intermediate- and poor-risk germ cell tumors: do we need to reclassify patients with metastatic germ cell tumors?","volume":"14","author":"Necchi","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2016.07.022_bib8","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S1470-2045(14)70490-5","article-title":"Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial","volume":"15","author":"Fizazi","year":"2014","journal-title":"Lancet Oncol"},{"issue":"suppl","key":"10.1016\/j.clgc.2016.07.022_bib9","article-title":"A\u00a0retrospective analysis of patients with intermediate-risk germ cell tumor (IRGCT) treated at Indiana University from 2000 to 2010","volume":"30","author":"Albany","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.07.022_bib10","doi-asserted-by":"crossref","first-page":"332.e19","DOI":"10.1016\/j.urolonc.2015.04.008","article-title":"Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: implications for clinical practice, trial design, and molecular interrogation","volume":"33","author":"Raggi","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2016.07.022_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clgc.2015.02.002","article-title":"Clinical outcomes of metastatic poor prognosis germ cell tumors: current perspective from a referral center","volume":"13","author":"Necchi","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2016.07.022_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/annonc\/mdw045","article-title":"Prognostic factors in patients with poor risk germ cell tumors: a retrospective analysis of the Indiana University experience from 1990-2014","volume":"27","author":"Adra","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2016.07.022_bib13","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/1097-0142(20010401)91:7<1304::AID-CNCR1133>3.0.CO;2-A","article-title":"Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era","volume":"91","author":"Sonneveld","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2016.07.022_bib14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1200\/JCO.2015.64.7909","article-title":"Conditional survival of patients with metastatic testicular germ cell tumors treated with first-line curative therapy","volume":"34","author":"Ko","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.clgc.2016.07.022_bib15","article-title":"Germ cell cancer (GCC): long-term survival after treatment with bleomycin (B), etoposide (E) and cisplatin (P) in a large cohort","volume":"31","author":"Gundgaard","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.07.022_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.clgc.2016.07.022_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.eururo.2011.04.029","article-title":"How to tell if a new marker improves prediction","volume":"60","author":"Nguyen","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2016.07.022_bib18","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2010.32.3204","article-title":"Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients","volume":"29","author":"Fossa","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.07.022_bib19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/jnci\/91.10.839","volume":"91","author":"Collette","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767316302257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767316302257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:26:17Z","timestamp":1761564377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767316302257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1558767316302257"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2016.07.022","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2016.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}